TWD 17.5
(-0.57%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 88.71 Million TWD | -31.92% |
2022 | 198.79 Million TWD | 589.64% |
2021 | 28.82 Million TWD | -74.19% |
2020 | 111.69 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 23.67 Million TWD | 0.0% |
2024 Q1 | 23.67 Million TWD | 25.24% |
2023 Q4 | 18.9 Million TWD | 0.0% |
2023 FY | 135.34 Million TWD | -31.92% |
2023 Q3 | 18.9 Million TWD | -25.75% |
2023 Q2 | 25.45 Million TWD | 0.0% |
2023 Q1 | 25.45 Million TWD | -7.14% |
2022 FY | 198.79 Million TWD | 589.64% |
2022 Q4 | 27.41 Million TWD | 0.0% |
2021 FY | 28.82 Million TWD | -74.19% |
2020 FY | 111.69 Million TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
GeneFerm Biotechnology Co., Ltd. | 153.56 Million TWD | 42.23% |
Easywell Biomedicals, Inc. | -162.73 Million TWD | 154.513% |
TTY Biopharm Company Limited | 1.37 Billion TWD | 93.536% |
Synmosa Biopharma Corporation | 614.74 Million TWD | 85.569% |
Orient EuroPharma Co., Ltd. | 84.55 Million TWD | -4.92% |
Center Laboratories, Inc. | -79.26 Million TWD | 211.921% |
Tien Liang BioTech Co., Ltd. | 20.43 Million TWD | -334.106% |
Orient Pharma Co., Ltd. | 27.75 Million TWD | -219.656% |
InnoPharmax Inc. | -64.83 Million TWD | 236.822% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 105.57 Million TWD | 15.967% |
Excelsior Biopharma Inc. | -81.12 Million TWD | 209.351% |
DV Biomed Co., Ltd. | 173.54 Million TWD | 48.882% |
Foresee Pharmaceuticals Co., Ltd. | -1 Billion TWD | 108.804% |
Handa Pharmaceuticals, Inc. | 695.79 Million TWD | 87.25% |
UniPharma Co., Ltd. | -27.3 Million TWD | 424.9% |
Anxo Pharmaceutical Co., Ltd. | 53.15 Million TWD | -66.903% |
Alar Pharmaceuticals Inc. | 385.52 Million TWD | 76.989% |
Winston Medical Supply Co., Ltd. | 196.1 Million TWD | 54.761% |
Mercury Biopharmaceutical Corporation | -45.69 Million TWD | 294.165% |
Bioray Biotech Co., Ltd | -19.33 Million TWD | 558.921% |
TSH Biopharm Corporation Limited | 63.63 Million TWD | -39.422% |